Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohorts
Abstract Obesity is a risk factor for type 2 diabetes and cardiovascular disease. However, a substantial proportion of patients with these conditions have a seemingly normal body mass index (BMI). Conversely, not all obese individuals present with metabolic disorders giving rise to the concept of “m...
Main Authors: | Habtamu B. Beyene, Corey Giles, Kevin Huynh, Tingting Wang, Michelle Cinel, Natalie A. Mellett, Gavriel Olshansky, Thomas G. Meikle, Gerald F. Watts, Joseph Hung, Jennie Hui, Gemma Cadby, John Beilby, John Blangero, Eric K. Moses, Jonathan E. Shaw, Dianna J. Magliano, Peter J. Meikle |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-41963-7 |
Similar Items
-
A lipidomic based metabolic age score captures cardiometabolic risk independent of chronological ageResearch in context
by: Tingting Wang, et al.
Published: (2024-07-01) -
Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over studyResearch in context
by: Habtamu B. Beyene, et al.
Published: (2024-07-01) -
Imputation of plasma lipid species to facilitate integration of lipidomic datasets
by: Aleksandar Dakic, et al.
Published: (2024-02-01) -
The potential of integrating human and mouse discovery platforms to advance our understanding of cardiometabolic diseases
by: Aaron W Jurrjens, et al.
Published: (2023-03-01) -
BMI and Cardiometabolic Traits in Japanese: A Mendelian Randomization Study
by: Mako Nagayoshi, et al.
Published: (2024-02-01)